Diphtheria and Tetanus Antitoxoid
*Build Your Own Panel Eligible [?]
|
$143
|
|
|
Description:
Tetanus is a life-threatening bacterial infection. The bacteria usually get into the body through a cut or wound in the skin. The bacteria make a powerful poison that causes muscles to contract uncontrollably in spasms. Tetanus is especially dangerous in young children and older adults.
Diphtheria spreads when germs pass from an infected person to the nose or throat of others. Diphtheria causes a thick coating in the nose, throat or airway and can lead to breathing problems, heart failure, paralysis or death.
This test assesses immunity against tetanus and diphtheria by determining levels of circulating antibodies to tetanus and diphtheria toxin or to measure the immune response, postvaccination, in individuals suspected of immunodeficiency disorders.
Significant deviations from the normal range may require further evaluation by your physician.
Includes:
Diphtheria Antitoxoid
Tetanus Antitoxoid
Categories:
Immunization blood testing,
Price:
$143
|
|
Diphtheria Antitoxoid
*Build Your Own Panel Eligible [?]
|
$124
|
|
|
Description:
Used to evaluate diphtheria immunization response. Antibody levels of ≥0.10 IU/mL are considered protective.
Categories:
Price:
$124
|
|
Diphtheria Antitoxoid, Endpoint Determination
*Build Your Own Panel Eligible [?]
|
$353
|
|
|
Description:
Used to evaluate diphtheria immunization response. Antibody levels of ≥0.10 IU/mL are considered protective.
Categories:
Price:
$353
|
|
Direct Antiglobulin Test (DAT)
*Build Your Own Panel Eligible [?]
|
$74
|
|
|
Description:
The DAT (Direct Coomb's test) is positive if red cells have been coated, in vivo, with immunoglobulin, complement, or both. A positive result can occur in immune-mediated red cell destruction, autoimmune hemolytic anemia, a transfusion reaction or in patients receiving certain drugs.
Categories:
Price:
$74
|
|
Direct Antiglobulin Test (DAT) with Reflex to Anti C3 and Anti IgG
*Build Your Own Panel Eligible [?]
|
$74
|
|
|
Description:
The DAT (Direct Coomb's test) is positive if red cells have been coated, in vivo, with immunoglobulin, complement, or both. A positive result can occur in immune-mediated red cell destruction, autoimmune hemolytic anemia, a transfusion reaction or in patients receiving certain drugs.
Categories:
Price:
$74
|
|
Direct LDL
*Build Your Own Panel Eligible [?]
|
$88
|
|
Description:
- Measures LDL cholesterol directly
- Helps assess heart disease risk
- Important for managing cholesterol levels
Includes:
Direct LDL
Patient Instructions:
Patient should fast for 12-14 hours prior to collection of the specimen.
Categories:
Price:
$88
|
|
Disaccharidases
*Build Your Own Panel Eligible [?]
|
$734
|
|
|
Description:
Lactase, maltase, palatinase and sucrase are mucosal disaccharidases that are present in normal small intestine and fetal colon. A decrease in the enzyme activity of these disaccharidases has been noted in colonic adenomas, adenocarcinomas and malabsorption. Decreased disaccharidase activity is a good indication of mucosal injury with the exception of lactase.
Categories:
Price:
$734
|
|
Disopyramide
*Build Your Own Panel Eligible [?]
|
$313
|
|
|
Description:
Disopyramide is useful in treating patients with cardiac arrhythmias and tachcardia. Therapeutic drug monitoring is useful to optimize dose and avoid toxicity.
Categories:
Price:
$313
|
|
Diuretics Screen, Urine
*Build Your Own Panel Eligible [?]
|
$415
|
|
|
Description:
Exclusion screen
Categories:
Price:
$415
|
|
DLBCL Mutation Analysis Only
*Build Your Own Panel Eligible [?]
|
$772
|
|
|
Description:
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.
Categories:
Price:
$772
|
|
DLBCL Profile
*Build Your Own Panel Eligible [?]
|
$2154
|
|
|
Description:
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.
Categories:
Price:
$2154
|
|
DMPK DNA Test (DM1)
*Build Your Own Panel Eligible [?]
|
$1493
|
|
|
Description:
Detects CTG repeat expansions in the muscle protein kinase (DMPK) gene.
Categories:
Price:
$1493
|
|
DNA (ds) Antibody, Crithidia IFA with Reflex to Titer
*Build Your Own Panel Eligible [?]
|
$318
|
|
|
Description:
dsDNA Antibody is detected in patients with active systemic lupus erythematosus (SLE) and approximately 20% of patients with mixed connective tissue disease.
Categories:
Price:
$318
|
|
DNase-B Antibody
*Build Your Own Panel Eligible [?]
|
$319
|
|
|
Description:
Documents recent streptococcal infection.
Categories:
Price:
$319
|
|
Dog Dander Component Panel
*Build Your Own Panel Eligible [?]
|
$346
|
|
|
Description:
Like respiratory allergies, animal allergies pose a significant risk for the development of asthma and rhinitis. Blood IgE tests using whole allergen extracts from dogs provide a sensitive screening method to diagnose pet sensitization. In addition, the dog dander component panel is an IgE blood test using individual recombinant proteins from dogs, improving specificity compared to animal extract assays. Thus, the dog dander component panel helps differentiate an actual dog allergy from a cross-reactive pet allergy.
Categories:
Price:
$346
|
|
Dog Dander (e5) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test quantifies an individual's IgE response to dog dander. Allergen-specific serum IgE testing is considered comparable to skin testing and may be preferred in some clinical situations. However, a positive test result only indicates that a patient is sensitized to the allergen of concern. Many IgE-sensitized individuals do not develop any symptoms when exposed to the allergen. A diagnosis of allergy should only be made by a trained medical provider after conducting a thorough clinical evaluation [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Dog Dander (e5) IgE with Reflex to Component Panel
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
Like respiratory allergies, animal allergies pose a significant risk for the development of asthma and rhinitis. Blood IgE tests using whole allergen extracts from dogs provide a sensitive screening method to diagnose pet sensitization. In addition, the dog dander component panel is an IgE blood test using individual recombinant proteins from dogs, improving specificity compared to animal extract assays. Thus, the dog dander component panel helps differentiate an actual dog allergy from a cross-reactive pet allergy.
Categories:
Price:
$49
|
|
Dog Dander IgG4
*Build Your Own Panel Eligible [?]
|
$254
|
|
Description:
- Check for dog allergy triggers
- Screen sneezing and itchy eyes causes
- Detect skin rash allergy reactions
Categories:
Price:
$254
|
|
Dog Fennel (w46) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This allergen-specific IgE antibody test quantifies an individual’s IgE response to dogfennel. It is an in vitro quantitative assay that is intended to be used in conjunction with other clinical information to aid in the diagnosis of allergic diseases [1]. While allergen-specific serum IgE testing is considered comparable to skin testing in many instances, both the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology recognize that allergen-specific serum IgE testing may be preferred in some clinical situations. These include 1) the presence of widespread skin disease, 2) the recent use of antihistamines or other medications that can affect the results of allergy skin tests, 3) uncooperative patients, and 4) medical history suggesting that allergen skin testing would pose a significant risk for a serious allergic reaction [1]. A definitive clinical diagnosis of allergy should not be based on the results of any single diagnostic method, but should be made by a trained healthcare provider after all clinical and laboratory findings have been evaluated. More specific information about this allergen can be found at http://www.phadia.com/en/products/allergy-testing-products/immunocap-allergen-information/weed-pollens/allergens/dog-fennel1/ Reference 1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Dog Serum Albumin (Re221) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against dog serum albumin. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
|
Donor, Chagas Screen
*Build Your Own Panel Eligible [?]
|
$360
|
|
|
Description:
Trypanosoma cruzi is a flagellated, protozoan parasite, which is endemic to regions of South and Central America and Mexico. It is the causative agent of Chagas Disease. Infection is chronic, asymptomatic and untreatable. The Chagas screening assay detects antibodies to T. cruzi and is used to screen blood and tissue donors.
Categories:
Price:
$360
|
|
Donor, Chlamydia trachomatis/Neisseria gonorrhoeae, RNA, TMA
*Build Your Own Panel Eligible [?]
|
$477
|
|
|
Description:
This test is intended to be used as the primary screening test for the diagnosis of infection with Chlamydia trachomatis or Neisseria gonorrhoeae and is required for screening all potential semen or egg donors for in vitro fertilization or other reproductive procedures; reactive results may be sufficient to consider a donor ineligible.
Categories:
Price:
$477
|
|
Donor, HIV/HCV/HBV NAT Procleix® with Reflexes
*Build Your Own Panel Eligible [?]
|
$968
|
|
|
Description:
The Procleix® Ultrio® Elite HIV/HBV/HCV Assay is a qualitative in vitro nucleic acid assay for the detection in Human Immunodeficiency Virus RNA, Hepatitis B Virus DNA, and Hepatitis C Virus RNA in human plasma. The test is intended to be used to screen blood, solid organ, and tissue donors for these agents. When used in conjunction with licensed tests for detecting antibodies to HIV, HBV, and HCV, test results may be used to determine eligibility for blood, solid organs, or tissue transplantation.
Categories:
Price:
$968
|
|
Donor, Syphilis IgG Antibody
*Build Your Own Panel Eligible [?]
|
$359
|
|
|
Description:
Detection of treponemal antibodies may indicate recent, past, or successfully treated syphilis infections, therefore, the test cannot be used to differentiate between active and cured cases. A reactive syphilis antibody test result may be used to disqualify a potential blood, cell or tissue donor.
Categories:
Price:
$359
|
|
Donor, West Nile Virus, NAT
*Build Your Own Panel Eligible [?]
|
$437
|
|
Description:
- Detect if you recently caught West Nile
- Screen for early signs of infection
- Identify risk of spreading illness to others
Includes:
Donor, West Nile Virus, NAT
Categories:
Price:
$437
|
|
Dopamine, Plasma
*Build Your Own Panel Eligible [?]
|
$415
|
|
|
Description:
Measurement of dopamine levels in urine or blood in addition to urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels may aid in the biochemical diagnosis and monitoring of neuroblastomas [1]. This test may also be useful in evaluating dopamine-secreting pheochromocytomas and paragangliomas (PPGLs) [2].Neuroblastomas occur predominantly in children and are the most common malignancy under 1 year old. Neuroblastomas are catecholamine-metabolizing tumors, and thus catecholamine metabolites (including VMA and HVA) are more reliable than catecholamines as biochemical markers for neuroblastomas [1]. However, urinary VMA and HVA levels may have limited accuracy for diagnosis of neuroblastomas with high-risk metastatic biology [1]. Because poor prognosis is associated with immaturity of catecholamine metabolism, dopamine levels in urine or blood have been proposed as an additional marker to aid in diagnosis and monitoring of neuroblastomas [3].Most PPGLs secrete catecholamines, but the relative amount of dopamine, norepinephrine, and epinephrine varies widely. Measurements of plasma free or urinary fractionated metanephrines (ie, the O-methylated catecholamine metabolites) are recommended by the Endocrine Society for the initial biochemical testing of PPGLs [4]. In patients with high clinical suspicion but normal blood pressure and normal levels of metanephrines, measurement of dopamine and its metabolites (HVA and methoxytyramine) may help diagnose PPGLs that predominantly secrete dopamine [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Eisenhofer G. Monoamine-producing tumors. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Jain A, et al. Pediatr Nephrol. 2020;35(4):581-594.3. Brodeur GM, et al. J Clin Oncol. 1993;11(8):1466-1477.4. Lenders JW, et al. J Clin Endocrinol Metab. 2014;99(6):1915-1942
Categories:
Price:
$415
|
|
Dopamine, Random Urine
*Build Your Own Panel Eligible [?]
|
$316
|
|
|
Description:
Measurement of dopamine levels in urine or blood in addition to urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels may aid in the biochemical diagnosis and monitoring of neuroblastomas [1]. This test may also be useful in evaluating dopamine-secreting pheochromocytomas and paragangliomas (PPGLs) [2].Neuroblastomas occur predominantly in children and are the most common malignancy under 1 year old. Neuroblastomas are catecholamine-metabolizing tumors with limited ability to store and secrete catecholamines. Thus, catecholamine metabolites (including VMA and HVA) are more reliable than catecholamines as biochemical markers for neuroblastomas [1]. However, urinary VMA and HVA levels may have limited accuracy for diagnosis of neuroblastomas with high-risk metastatic biology [1]. Because poor prognosis is associated with immaturity of catecholamine metabolism, dopamine levels in urine or blood have been proposed as an additional marker to aid in diagnosis and monitoring of neuroblastomas [3].Most PPGLs secrete catecholamines, but the relative amount of dopamine, norepinephrine, and epinephrine varies widely. Measurements of plasma free or urinary fractionated metanephrines (ie, the O-methylated catecholamine metabolites) are recommended by the Endocrine Society for the initial biochemical testing of PPGLs [4]. In patients with high clinical suspicion but normal blood pressure and normal levels of metanephrines, measurement of dopamine and its metabolites (HVA and methoxytyramine) may help diagnose PPGLs that predominantly secrete dopamine [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Eisenhofer G. Monoamine-producing tumors. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management. Pediatr Nephrol. 2020;35(4):581-594. doi:10.1007/s00467-018-4181-23. Brodeur GM, et al. J Clin Oncol. 1993;11(8):1466-1477.4. Lenders JW, et al. J Clin Endocrinol Metab. 2014;99(6):1915-1942
Categories:
Price:
$316
|
|
Dopamine, Urine
*Build Your Own Panel Eligible [?]
|
$316
|
|
|
Description:
Measurement of dopamine levels in urine or blood in addition to urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels may aid in the biochemical diagnosis and monitoring of neuroblastomas [1]. This test may also be useful in evaluating dopamine-secreting pheochromocytomas and paragangliomas (PPGLs) [2].Neuroblastomas occur predominantly in children and are the most common malignancy under 1 year old. Neuroblastomas are catecholamine-metabolizing tumors with limited ability to store and secrete catecholamines. Thus, catecholamine metabolites (including VMA and HVA) are more reliable than catecholamines as biochemical markers for neuroblastomas [1]. However, urinary VMA and HVA levels may have limited accuracy for diagnosis of neuroblastomas with high-risk metastatic biology [1]. Because poor prognosis is associated with immaturity of catecholamine metabolism, dopamine levels in urine or blood have been proposed as an additional marker to aid in diagnosis and monitoring of neuroblastomas [3].Most PPGLs secrete catecholamines, but the relative amounts of dopamine, norepinephrine, and epinephrine vary widely. Measurements of plasma free or urinary fractionated metanephrines (ie, the O-methylated catecholamine metabolites) are recommended by the Endocrine Society for the initial biochemical testing of PPGLs [4]. In patients with high clinical suspicion but normal blood pressure and normal levels of metanephrines, measurement of dopamine and its metabolites (HVA and methoxytyramine) may help diagnose PPGLs that predominantly secrete dopamine [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Eisenhofer G. Monoamine-producing tumors. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Jain A, et al. Pediatr Nephrol. 2020;35(4):581-594.3. Brodeur GM, et al. J Clin Oncol. 1993;11(8):1466-1477.4. Lenders JW, et al. J Clin Endocrinol Metab. 2014;99(6):1915-1942
Categories:
Price:
$316
|
|
Doxepin
*Build Your Own Panel Eligible [?]
|
$356
|
|
|
Description:
Doxepin is a tricyclic antidepressant. Therapeutic drug levels are monitored to assist the physician assessing therapeutic response and to avoid toxicity.
Categories:
Price:
$356
|
|
Doxycycline
*Build Your Own Panel Eligible [?]
|
$372
|
|
|
Description:
The concentration of antimicrobial agents in body fluids, most notably serum or plasma, are used to regulate therapy to ensure effective dosing (especially with oral agents where GI absorption is in question), to monitor accumulation to help minimize toxicity, and to help evaluate the pharmacokinetics of new agents. Both peak and trough levels obtained immediately after dosing or immediately prior to new dosing, respectively, may be monitored.
Categories:
Price:
$372
|
|
DPPX Receptor Antibody, CBA
*Build Your Own Panel Eligible [?]
|
$411
|
|
|
Description:
Dipeptidyl peptidase-like protein 6 (DPPX) is a regulatory subunit of voltage gated potassium channels in neurons of the central nervous system. Antibodies to DPPX have been associated with agitation, confusion, amnesia, delirium, allodynia, myoclonus, rigidity, tremor, exaggerated startle, ataxia, dysphagia, dysarthria seizures, psychosis, depression, sleep disturbance, respiratory failure and unexplained diarrhea, gastroparesis constipation, bladder dysautonomia, and abnormalities in cardiac conduction and thermoregulation.
Categories:
Price:
$411
|
|
D. pteronyssinus Mite IgG4
*Build Your Own Panel Eligible [?]
|
$245
|
|
Description:
- Check indoor dust mite allergy triggers
- Detect sneezing and congestion causes
- Screen for chronic itchy eye symptoms
Categories:
Price:
$245
|
|
Drug Monitoring, Alcohol Metabolite, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are minor metabolite of ethanol metabolites and excreted in urine for a longer time than ethanol. Positive EtG and/or EtS test results thus provide a strong indication that the person has recently consumed alcohol, even when ethanol is no longer detectable. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of these metabolites is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns.
Categories:
Price:
$326
|
|
Drug Monitoring, Alcohol Metabolite, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
Ethyl glucuronide and ethyl sulfate are metabolites of ethanol (alcohol) that may be present in urine after ingestion of, or exposure to, drinks, foods, medication or other products containing ethyl alcohol. Incidental exposure to alcohol-containing products such as mouthwash or hand sanitizer have also been shown to produce positive alcohol metabolites test results. LC-MS/MS testing detects EtG and EtS regardless of the source. Therefore, we encourage you to interpret alcohol metabolite test results in light of the clinical picture.
Categories:
Price:
$446
|
|
Drug Monitoring, Amphetamines, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
The amphetamine class of drugs are traditionally classified as stimulants. Some members of the class (amphetamine) are prescribed for treatment of attention-deficit hyperactivity disorder (ADHD), to suppress appetite, and for narcolepsy. Other members of the class are considered drugs of abuse (methamphetamine, MDMA) with no accepted medical uses. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the amphetamines and their metabolites is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Amphetamines, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The amphetamine class of drugs are traditionally classified as stimulants. Some members of the class (amphetamine) are prescribed for treatment of attention-deficit hyperactivity disorder (ADHD), to suppress appetite, and for narcolepsy. Other members of the class are considered drugs of abuse (methamphetamine, MDMA) with no accepted medical uses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the amphetamines and their metabolites is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Amphetamines, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The amphetamine class of drugs are traditionally classified as stimulants. Some members of the class (amphetamine) are prescribed for treatment of attention-deficit hyperactivity disorder (ADHD), to suppress appetite, and for narcolepsy. Other members of the class are considered drugs of abuse (methamphetamine, MDMA) with no accepted medical uses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring of the amphetamines and their metabolites is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$446
|
|
Drug Monitoring, Amphetamines, with Confirmation, with D/L, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The amphetamine class of drugs are traditionally classified as stimulants. Some members of the class (amphetamine) are prescribed for treatment of attention-deficit hyperactivity disorder (ADHD), to suppress appetite, and for narcolepsy. Other members of the class are considered drugs of abuse (methamphetamine, MDMA) with no accepted medical uses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test.Additionally, if methamphetamine is confirmed by LC/MS/MS, an additional confirmation procedure will be done to determine the specific isomer that is present. Therapeutic urine drug monitoring of the amphetamines and their metabolites is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
|
Drug Monitoring, Amphetamines, with D/L, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
Methamphetamine has two isomers, d-methamphetamine (dextromethamphetamine) and l-methamphetamine (levomethamphetamine). d-methamphetamine is most often illicitly manufactured and is considered a drug of abuse (Crystal meth, etc.). It is approved as a treatment for ADHD and obesity, although its use is very limited. l-methamphetamine is used in certain nonprescription inhalers as a decongestant. This test is a definitive assay using a gas chromatography mass spectroscopy (GC-MS) method of analysis. In routine confirmation testing of amphetamines, the specific methamphetamine isomers are not differentiated, and reported as "Methamphetamine". In situations where this is an unexpected result, it may be useful to determine the relative percentages of each isomer present. The presence of the l-isomer at greater than 80% is consistent with the use of non-prescription inhalers. The presence of the d-isomer greater than 20% is consistent with the use of prescribed medication or illegally manufactured methamphetamine. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Antidepressants, with Confirmation, Serum
*Build Your Own Panel Eligible [?]
|
$387
|
|
|
Description:
Antidepressants are medications that can be used to treat mild, moderate, and severe depression. These medications may also be used to treat anxiety and eating disorders as well as pain (fibromyalgia and neuropathic). Antidepressant drug testing is intended for use in prescription adherence monitoring of patients prescribed antidepressant medications. Adherence monitoring requires prescribed drugs to be present, and the absence of non-prescribed drugs for these patient populations. Drug testing for prescription adherence can provide information for improvement of patient care. The results of drug testing can often prompt important clinical discussions with patients.
Categories:
Price:
$387
|
|
Drug Monitoring, Antidepressants, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$387
|
|
|
Description:
The monitoring of the parent compounds and metabolites in urine of the group of drugs classified as Antidepressants.
Categories:
Price:
$387
|
|
Drug Monitoring, Antipsychotics, with Confirmation, Serum
*Build Your Own Panel Eligible [?]
|
$387
|
|
|
Description:
Antipsychotic (AP) drugs are widely prescribed for the treatment of schizophrenia and psychosis. The so-called first generation or typical APs were developed in the 1950s and show severe side-effects such as extrapyramidal symptoms due to their pharmacological action on d2 and d4 receptors. As a measure of reducing these severe side-effects, a range of ‘second generation’ APs were developed. These newer generation drugs act considerably less on d2 and d4 receptors and therefore exhibit less extrapyramidal side-effects. Over the last decade, the prescription rate of APs (more notably second generation) has increased worldwide, [1-3] especially among young adults and children [1-4]. However, second generation APs are not entirely free of side-effects. Irrespective of their generation, it has been shown that these drugs can increase the risk of sudden cardiac death with studies showing that the risk of sudden cardiac death is increased threefold among patients treated with APs.
Categories:
Price:
$387
|
|
Drug Monitoring, Antipsychotics, with Confirmation, Urine
*Build Your Own Panel Eligible [?]
|
$387
|
|
|
Description:
Antipsychotic (AP) drugs are widely prescribed for the treatment of schizophrenia and psychosis. The so-called first generation or typical APs were developed in the 1950s and show severe side-effects such as extrapyramidal symptoms due to their pharmacological action on d2 and d4 receptors. As a measure of reducing these severe side-effects, a range of ‘second generation’ APs were developed. These newer generation drugs act considerably less on d2 and d4 receptors and therefore exhibit less extrapyramidal side-effects. Over the last decade, the prescription rate of APs (more notably second generation) has increased worldwide, [1-3] especially among young adults and children [1-4]. However, second generation APs are not entirely free of side-effects. Irrespective of their generation, it has been shown that these drugs can increase the risk of sudden cardiac death with studies showing that the risk of sudden cardiac death is increased threefold among patients treated with APs.
Categories:
Price:
$387
|
|
Drug Monitoring Assess Panel, Base, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$1245
|
|
|
Description:
A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$1245
|
|
Drug Monitoring Assess Panel, Comprehensive, Qualitative, Urine
*Build Your Own Panel Eligible [?]
|
$742
|
|
|
Description:
In an emergency medicine or acute care setting, a definitive qualitative assessment of the presence of different drugs can be critical to patient care. Absence of an expected drug could suggest poor adherence or diversion whereas detection of a non-prescribed licit or illicit drug could indicate substance misuse or toxicity. Discrepancies between expected and actual results also call attention to potential medical factors affecting drug disposition. Drug cutoffs in this panel are targeted to detect potentially toxic or overdose situations. This assay is not intended for monitoring routine use of prescription substances.
Categories:
Price:
$742
|
|
Drug Monitoring Assess Panel, Extended, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$3923
|
|
|
Description:
A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$3923
|
|
Drug Monitoring Assess Panel, Plus, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$1602
|
|
|
Description:
A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$1602
|
|
Drug Monitoring Assess Panel, Volatiles, Urine
*Build Your Own Panel Eligible [?]
|
$327
|
|
|
Description:
Ethanol is the most commonly abused substance whose primary effect on the central nervous system varies with blood concentration. Not all individuals experience the same effects at a given blood level. Additionally, other central nervous system depressants can have an additive effect when taken in combination with ethanol. Approximately 5% of ethanol is excreted unchanged in urine. A positive urine ethanol result may suggest recent ethanol exposure and/or consumption; however, in diabetic patients with a urinary tract infection, ethanol is commonly present in urine as a result of glucose fermentation by yeast in the urine. When fermentation is not suspected, and urine ethanol is adjusted by a sample's creatinine concentration, urine ethanol may be used to estimate blood ethanol concentrations, as urine ethanol concentrations are approximately 130% of blood concentrations, if the patient is in the elimination phase. Caution should be exercised with interpretation of urine ethanol results; it is not recommended that a clinical decision be based solely on a urine ethanol result as there are several different scenarios that may have yielded the result.
Categories:
Price:
$327
|
|
Drug Monitoring, Barbiturates, Quantitative, Urine
*Build Your Own Panel Eligible [?]
|
$326
|
|
|
Description:
The barbiturate class of drugs are substances that are traditionally classified as sedatives. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. They are central nervous system (CNS) depressants. The test is a definitive assay using gas chromatography mass spectroscopy (GC/MS) methodology. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.
Categories:
Price:
$326
|
|
Drug Monitoring, Barbiturates, Screen, Urine
*Build Your Own Panel Eligible [?]
|
$446
|
|
|
Description:
The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.
Categories:
Price:
$446
|
